BioNTech counts on shift to cancer drugs after second quarter losses quadruple
LOSSES at German drugmaker BioNTech quadrupled in the second quarter from a year earlier, the company said on Monday (Aug ...
LOSSES at German drugmaker BioNTech quadrupled in the second quarter from a year earlier, the company said on Monday (Aug ...
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday (Apr 25), accusing them of infringing GSK patents related ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
© 2024 The New York Journals. All Rights Reserved.